Cargando…

Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy

Aberrant expression of genes contributes to the chemoresistance of colorectal cancer (CRC) treatment. This study aimed to identify genes associated with the chemoresistance of oxaliplatin-based chemotherapy in CRC patients and to construct a signature. Oxaliplatin resistance-related genes were scree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yixin, Li, Siqi, Liang, Xinqiang, Li, Kezhi, Xie, Mingzhi, Hu, Bangli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503614/ https://www.ncbi.nlm.nih.gov/pubmed/36145360 http://dx.doi.org/10.3390/ph15091139

Ejemplares similares

Association and diagnostic value of serum SPINK4 in colorectal cancer
por: Xie, Mingzhi, et al.
Publicado: (2019)

Insights on Ferroptosis and Colorectal Cancer: Progress and Updates
por: Hu, Bangli, et al.
Publicado: (2022)

External validation of anastomotic leakage risk analysis system in patients who underwent colorectal resection
por: ER, Sadettin, et al.
Publicado: (2019)

Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
por: Choi, Ji Hoon, et al.
Publicado: (2014)

The association and diagnostic value of red blood cell distribution width in colorectal cancer
por: Shi, Cheng, et al.
Publicado: (2019)

Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy
por: Park, Hanla A., et al.
Publicado: (2022)

Collagenous Colitis in a Patient With Gastric Cancer Who Underwent Chemotherapy
por: Iwamuro, Masaya, et al.
Publicado: (2023)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2003)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Alliot, C, et al.
Publicado: (2004)

Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2004)

miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer
por: Xie, Xu-Qin, et al.
Publicado: (2020)

Surgical Outcomes and Risk Factors in Patients Who Underwent Emergency Colorectal Surgery
por: Jeong, Dai Sik, et al.
Publicado: (2017)

Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer
por: Park, Dawon, et al.
Publicado: (2018)

PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
por: Sfakianaki, Maria, et al.
Publicado: (2020)

Adjuvant oxaliplatin-based chemotherapy effect after treatment of colorectal hepatic metastasis
por: Kang, Mee-Young, et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer
por: Randrian, Violaine, et al.
Publicado: (2022)

Construction of Nomogram-Based Prediction Model for Clinical Prognosis of Patients with Stage II and III Colon Cancer Who Underwent Xelox Chemotherapy after Laparoscopic Radical Resection
por: Sun, Qiang, et al.
Publicado: (2022)

Translational Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Oxaliplatin and Irinotecan in Colorectal Cancer
por: Zhu, Jinwei, et al.
Publicado: (2023)

Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy
por: Tang, Zhanpeng, et al.
Publicado: (2022)

Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy
por: Chen, Jianfang, et al.
Publicado: (2016)

Outcomes and Risk Factors Affecting Mortality in Patients Who Underwent Colorectal Emergency Surgery
por: Oh, Nam Ho, et al.
Publicado: (2016)

Perforated colorectal cancers: clinical outcomes of 18 patients who underwent emergency surgery
por: Gök, Mehmet Ali, et al.
Publicado: (2021)

Clinical characteristics of patients in their forties who underwent surgical resection for colorectal cancer in Korea
por: Lee, Chang Sin, et al.
Publicado: (2021)

Characteristics of positive horizontal margins in patients who underwent colorectal endoscopic submucosal dissection
por: Kawashima, Kazumasa, et al.
Publicado: (2023)

Association of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
por: Rivera Franco, Monica M., et al.
Publicado: (2016)

Vincristine induced neurotoxicity in children who underwent chemotherapy for acute lymphoblastic leukemia and Wilms tumor
por: Adil, Muhammad Kamran, et al.
Publicado: (2021)

A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer
por: Wang, Qinchuan, et al.
Publicado: (2020)

The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
por: Hayashi, Naomi, et al.
Publicado: (2020)

Chemotherapy-Associated Hepatopathy in Korean Colorectal Cancer Liver Metastasis Patients: Oxaliplatin-Based Chemotherapy and Sinusoidal Injury
por: Nam, Soo Jeong, et al.
Publicado: (2012)

Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment – oxaliplatin subscale: a prospective cohort study
por: Gu, Zhancheng, et al.
Publicado: (2023)

Screening of molecular targets and construction of a ceRNA network for oxaliplatin resistance in colorectal cancer
por: Wei, Wu, et al.
Publicado: (2019)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
por: Zhou, Qing-nan, et al.
Publicado: (2023)

Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein
por: Tang, Yanping, et al.
Publicado: (2022)

Tumor deposit is an independent prognostic indicator in patients who underwent radical resection for colorectal cancer
por: Basnet, Shiva, et al.
Publicado: (2018)

Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
por: Kim, Hong Jun, et al.
Publicado: (2020)

The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
por: Lee, Janghee, et al.
Publicado: (2021)

Intestinal malrotation in a patient who underwent radical cystectomy and ileal conduit construction: A case report
por: Yamabe, Fumito, et al.
Publicado: (2019)

Use of a Smartphone Medical App Improves Complications and Quality of Life in Patients with Nasopharyngeal Carcinoma Who Underwent Radiotherapy and Chemotherapy
por: Di, Ruiqing, et al.
Publicado: (2018)

Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection
por: Zhao, Bochao, et al.
Publicado: (2023)

Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin
por: Matsuoka, Taisuke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i518h98j16la2pfrje8b1jo74p